% Expired Patents = 16.7

EPO Patents = 4

Forward Citations = 1

Loading Chart...

2 inventors (with patents filed for the assignee):

Dawei Zhang (6 out of 30 patents)

Xiaoyang Xia (1 out of 6 patents)

Dawei Zhang (1 patent)

6 patents: Sort by Forward Citations

1. 11427559 - Substituted quinolines useful as kinase inhibitors (2022-08-30),

2. 11344553 - Substituted pyrazolopyrimidines useful as kinases inhibitors (2022-05-31),

3. 11034656 - Maleate salts of (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereof (2021-06-15),

4. 10173995 - Pyridine compounds used as PI3 kinase inhibitors (2019-01-08),

5. 10159663 - Substituted macrocycles useful as kinases inhibitors and methods of use thereof (2018-12-25),

6. 9388160 - Quinazoline derivatives as kinases inhibitors and methods of use thereof (2016-07-12),

Company Overview

Teligene Ltd. is a leading biotechnology company specializing in genetic testing and personalized medicine. With a focus on precision health solutions, Teligene offers a range of genetic tests for individuals and healthcare professionals. Our mission is to empower individuals to make informed decisions about their health by providing accurate and reliable genetic information. Visit our website to learn more about our services and how we can help you unlock the secrets of your DNA.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#82 in Suzhou

#4,454 in China

Suzhou, China

Teligene Ltd.

Forward Citations = 1

2 inventors:

Dawei Zhang (6 out of 30 patents)

Xiaoyang Xia (1 out of 6 patents)

Dawei Zhang (1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Teligene Ltd.. Retrieved from https://idiyas.com/company/teligene

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]